Hi Xinting,
In a few rare cases, I've seen this happen if the model is approaching
nonconvergence. In those cases, typically the RSE on one or more parameters
will increase and the ratio of max to min eigenvalues will increase
substantially. Are you seeing either of these?
Thanks,
Bill
On
Second announcement:
Leonid and Ekaterina Gibiansky (QuantPharm LLC) will present the
workshop on Modeling of Biologics with Target-Mediated Disposition in
Maryland (near Baltimore), September 13, 2013.
The workshop provides an overview of the PK of biologics, introduces
target-mediated drug
Dear NONMEM users,
I am trying to build a model to describe the drug toxicity on neuropathy.
Since I am having dose and toxicity data, the K-PD model was applied in our
model. The distribution of baseline is heavily left skewed. So I am also
trying included the Box-cox transformation to get a accu
I sent wrong control stream in the previous mail. Sorry for this.
Please see the control stream below.
$SUBS ADVAN6 TOL=6
$MODEL
NCOMP=2
COMP=(DOSE)
COMP=(OBS)
$PK
KIN=THETA(1)*EXP(ETA(1))
BXPAR=THETA(2)
PHI=EXP(ETA(2))
ETATR=(PHI**BXPAR-1)/BXPAR
BASELINE=THETA(3)*
*The Third Annual Indiana Clinical and Translational Sciences Institute
(CTSI) Symposium *
*on Disease and Therapeutic Response Modeling *
*November 5 and 6, 2013*
We are pleased to announce that the third annual Indiana Clinical and
Translational Sciences Institute (CTSI) Symposium on Dis